Video

How Automation Reduces Batch-To-Batch Variability

An excerpt from Cell & Gene Live's How To Reduce Batch-to-Batch Variation In Cell Therapy Manufacturing featuring guests Omkar Kowlaker, Ph.D., Head of Manufacturing and Supply Chain at NextGen Therapies Consulting at Deloitte and Donna Rill, Chief Technology Officer at Triumvira Immunologics. In this segment, our experts share why changing from a manual process to an automated process is critical. Rill shares why automation will result in improved outcomes.

access the Video!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Cell & Gene

Please tell us more about you so that we can customize our newsletters to your specific interests:

Entegris, Inc.